- Top Workplaces
- Vividion Therapeutics
Vividion Therapeutics
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
Purpose
Despite advances in genomics, structural biology, and other scientific disciplines, 90 percent of the proteins in the body that are known to cause disease remain beyond the reach of available medicines. The massive scale of this undrugged target universe translates to a tremendous unmet need among patients with cancers and immunological diseases. The focus of our science is to demystify the undrugged and discover novel ways to modulate protein targets that have eluded conventional approaches.
Vision
Leading a breakthrough evolution in small molecule science … to extend and enhance the lives of patients suffering from devastating diseases.
Mission
Due to the limits of traditional drug discovery, the vast majority of known disease-causing proteins remain undrugged. Our mission is to unlock these targets and accelerate delivery of novel small molecule medicines to patients in need.
Recent Awards
Company Snapshots
